Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MacroGenics, Inc. - Common Stock (NQ:MGNX)

1.580 +0.040 (+2.60%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MacroGenics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Look Out For These 6 Stocks As Analysts Predicts Major Gains, One Up To 82%
Investment analysts have revised their price targets upwards for six major stocks this week, with one company expected to see an 82% surge. The revised targets include four U.S.-listed companies, with... 
Via Benzinga
MacroGenics Analyst Impressed By Improved Safety Profile From Prostate Cancer Candidate
Update on MacroGenics Inc's Phase 2 TAMARACK study of vobramitamab duocarmazine (vobra duo) for metastatic castration-resistant prostate cancer (mCRPC). Safety and preliminary efficacy data anticipated... 
Via Benzinga
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%... 
Via Benzinga
The Latest Analyst Ratings For Macrogenics
Via Benzinga
MacroGenics Inc. (NASDAQ: MGNX) Leading the Way in Thursday Trading Based on Percentage Gain
Via Investor Brand Network
Macrogenics: Q4 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining by around 90 points on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics (MGNX) Q4 2023 Earnings Call Transcript
MGNX earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
A Preview Of Macrogenics's Earnings
Via Benzinga
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 3/5
Via Investor Brand Network
Analyst Expectations For Macrogenics's Future
Via Benzinga
MGNX Stock Earnings: Macrogenics Misses EPS for Q4 2023
MGNX stock results show that Macrogenics missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
Decoding 4 Analyst Evaluations For Macrogenics
Via Benzinga
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 2/12
Via Investor Brand Network
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 2/6
Via Investor Brand Network
Earnings Scheduled For March 7, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
Via Benzinga
MicroMarvel MacroGenics Confuses Wall Street
100% technical buy signals. 15 new highs and up 66.53% last month. 280.00+ Weighted Alpha 
Via Talk Markets
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday
U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, Inc. (NASDAQ: SGRY) fell sharply during Monday’s session following weak... 
Via Benzinga
Topics Stocks
Exposures US Equities
MacroGenics to Participate in Upcoming Investor Conference
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 2/1
Via Investor Brand Network
Demystifying Macrogenics: Insights From 5 Analyst Reviews
Via Benzinga
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 1/23
Via Investor Brand Network
World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of World Acceptance Corporation (NASDAQ: WRLD) rose sharply during Friday’s session following upbeat... 
Via Benzinga
Topics Stocks
Exposures US Equities
The 3 Most Undervalued Biotech Stocks to Buy in January
These are a number of undervalued biotech companies that investor should possibly look to add to their portfolios. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.